Streetbeat News

Stock Prices

TXT

Analysts have provided various ratings for Textron (NYSE:TXT) within the last quarter, with an average price target of $86.2, implying an upside from the current price of $78.89. The current average has increased by 3.86% from the previous average price target of $83.00.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 2:00 pm

DAL

Delta Air Lines (NYSE:DAL) is set to release its quarterly earnings report on October 12, 2023. Analysts estimate an earnings per share (EPS) of $1.94. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $35.73, up 20.08% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 2:00 pm

VEEV

Veeva Systems (VEEV) has received a mix of bullish and indifferent ratings from 18 analysts over the last quarter. The average price target is $227.17, indicating an upside from the current price of $216.06. The average price target has increased by 9.37% over the past month.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 2:00 pm

PXD

XOM

Exxon Mobil Corporation has agreed to acquire Pioneer Natural Resources Company in an all-stock transaction valued at $59.5 billion. The deal represents an 18% premium to Pioneer's closing price on October 5. The acquisition is expected to close in the first half of 2024. Exxon's shares are trading lower after the announcement, while Pioneer's shares are trading higher.

Portfolio Pulse from Nabaparna Bhattacharya

October 11, 2023 | 1:56 pm

TKR

B of A Securities analyst Ross Gilardi has downgraded Timken (NYSE:TKR) from Neutral to Underperform and lowered the price target from $100 to $74.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:55 pm

BAX

DVA

FMS

LLY

NVO

Shares of DaVita Inc (DVA), Fresenius Medical Care AG (FMS), and Baxter International Inc (BAX) fell sharply due to Novo Nordisk A/S's (NVO) early termination of its semaglutide kidney outcomes trial FLOW due to early signs of efficacy. The GLP-1 drugs like semaglutide could potentially reduce the size of the dialysis patient population over time, negatively impacting the dialysis market. The announcement also strengthens the case for using GLP-1 drugs, including Eli Lilly And Co's (LLY) Mounjaro, in diabetes patients with chronic kidney disease.

Portfolio Pulse from Vandana Singh

October 11, 2023 | 1:53 pm

THRN

Evercore ISI Group's analyst Elizabeth Anderson has downgraded Thorne HealthTech (NASDAQ:THRN) from Outperform to Neutral.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:43 pm

ETWO

SILK

SPCB

TPST

VINO

WHLR

US stocks traded higher with the Dow Jones gaining over 100 points. Real estate shares surged by 1.1% while energy shares fell by 1.9%. US producer prices increased 0.5% month-over-month in September, above market expectations of 0.3%. Tempest Therapeutics, Wheeler Real Estate Investment Trust, and Gaucho Group Holdings saw significant stock price increases. Silk Road Medical, E2open Parent Holdings, and SuperCom Ltd. experienced notable drops in their stock prices.

Portfolio Pulse from Lisa Levin

October 11, 2023 | 1:40 pm

C3.Ai Inc (NYSE:AI) announced an expanded collaboration with Shell for asset monitoring and predictive monitoring. The C3 AI Reliability application will now include predictive maintenance software from Shell. The companies plan to pursue a roadmap that includes reliability and asset monitoring solutions, asset integrity, process and production optimization, and sustainability solutions. C3.ai shares climbed more than 8% on Tuesday and continue to move higher Wednesday.

Portfolio Pulse from Adam Eckert

October 11, 2023 | 1:37 pm

BIDU

BIRK

COST

GOOG

GSK

HUM

LVMHF

MGM

MNKTQ

NVO

QABSY

TPST

WBA

Several companies are in the news for various reasons. Alphabet and Discord are facing ethical concerns over Google's AI chatbot, Bard. MGM Resorts snubbed hackers' ransom demands after a cyberattack. Costco is accused of sharing confidential health data with Meta Platforms. Humana has appointed a new CEO. Novo Nordisk has stopped a kidney trial due to early signs of efficacy. Walgreens has appointed a new CEO. GSK has settled a lawsuit. LVMH reported a 9% organic revenue growth in Q3. Qantas Airways is overhauling its board. Tempest Therapeutics' stock soared after positive results from a clinical trial. Tech giants Baidu, Huawei, and Alibaba are setting standards for autonomous driving in China. Blackstone is in talks to acquire a stake in Disney's Indian subsidiary. Mallinckrodt's bankruptcy plan was approved. Birkenstock has priced its IPO.

Portfolio Pulse from Vandana Singh

October 11, 2023 | 1:36 pm